Finance

Lists
600267:SHA
Zhejiang Hisun Pharmaceutical Co., Ltd.
CNÂ¥11.64
-1.27%
(-0.15) 1D
Sep 4, 3:00:04 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600267...
Open
CNÂ¥11.82
High
CNÂ¥11.92
Low
CNÂ¥11.58
Mkt. cap
13.86B
Avg. vol.
52.33M
Volume
20.27M
Dividend
1.80%
Quarterly dividend
CNÂ¥0.05
Ex-dividend date
Jun 16, 2026
P/E ratio
15.42
52-wk high
CNÂ¥15.00
52-wk low
CNÂ¥9.35
EPS
CNÂ¥0.75
Shares outstanding
965.53M
No. of employees
9K
Open
CNÂ¥11.82
High
CNÂ¥11.92
Low
CNÂ¥11.58
Mkt. cap
13.86B
Avg. vol.
52.33M
Volume
20.27M
Dividend
1.80%
Quarterly dividend
CNÂ¥0.05
Ex-dividend date
Jun 16, 2026
P/E ratio
15.42
52-wk high
CNÂ¥15.00
52-wk low
CNÂ¥9.35
EPS
CNÂ¥0.75
Shares outstanding
965.53M
No. of employees
9K
About Zhejiang Hisun Pharmaceutical Co., Ltd.
CEO-
Employees8.75K
Founded1956
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.67B
2.63B
2.39B
2.09B
Cost of goods sold
1.37B
1.58B
1.17B
813.70M
Cost of revenue
1.37B
1.58B
1.17B
813.70M
Research and development expenses
169.79M
106.39M
134.44M
133.58M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
767.80M
723.79M
706.45M
709.18M
Operating expense
924.27M
897.41M
845.10M
863.22M
Total operating expenses
2.29B
2.48B
2.02B
1.68B
Operating income
382.05M
149.99M
370.87M
408.10M
Other non operating income
-22.42M
21.53M
-3.69M
-47.47M
EBT including unusual items
215.43M
195.64M
482.46M
341.11M
EBT excluding unusual items
337.55M
149.16M
529.80M
373.84M
Income tax expense
52.29M
116.21M
123.91M
57.95M
Effective tax rate
24.27%
59.40%
25.68%
16.99%
Other operating expenses
-14.72M
61.27M
12.09M
12.58M
Net income
161.86M
79.78M
355.69M
280.78M
Net profit margin
6.06%
3.04%
14.88%
13.47%
Earnings per share
-
-
-
-
Interest and investment income
2.80M
3.79M
179.34M
16.72M
Interest expense
-23.75M
-21.61M
-16.72M
-3.52M
Net interest expenses
-20.95M
-17.82M
162.62M
13.20M
Depreciation and amortization charges
-
-
-
-
EBITDA
648.89M
388.47M
609.35M
637.75M
Gain or loss from assets sale
305.01K
-5.23M
-
-849.83K
AI content may include mistakes. Learn more
Google apps